There were 1,831 press releases posted in the last 24 hours and 439,479 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Agios Submits Supplemental New Drug Application to FDA for TIBSOVO® (ivosidenib tablets) for Patients with Previously Treated IDH1-Mutant Cholangiocarcinoma

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image